Example: Heart Attack

Search clinical trials for: Anastrozole

Total 355 results

NCT04445922

Not yet recruiting

Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fed Condition

Conditions: Healthy Volunteers
NCT04438733

Recruiting

Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fasted Condition

Conditions: Healthy Volunteers
NCT01155960

Completed

Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fed Conditions

Conditions: Healthy
NCT01155947

Completed

Bioavailability Study of Anastrozole Tablets 1 mg of Dr.Reddy's Under Fasting Conditions

Conditions: Healthy
NCT03314298

Completed

A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole

Conditions: Mammographic Density
NCT03229499

Recruiting

Pulmonary Hypertension and Anastrozole Trial

Conditions: Pulmonary Arterial Hypertension
NCT02140437

Withdrawn

Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC

Conditions: Carcinoma Breast Stage IV
NCT01972984

Completed

Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer Patients

Conditions: Breast Cancer
NCT02730923

Active, not recruiting

Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)

Conditions: Endometrial Carcinoma; Metastatic Carcinoma; Hormone Receptor Positive Tumor
NCT00421447

Completed

Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole

Conditions: Breast Cancer
NCT03264651

Completed

Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density

Conditions: Mammographic Density
NCT00136695

Completed

Anastrozole Administration in Elderly Hypogonadal Men

Conditions: Hypogonadism
NCT04294225

Recruiting

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Early-Stage Breast Carcinoma; Invasive Breast Carcinoma; Prognostic Stage I Breast Cancer AJCC v8; Prognostic Stage IA Breast Cancer AJCC v8; Prognostic Stage IB Breast Cancer AJCC v8; Prognostic Stage II Breast Cancer AJCC v8; Prognostic Stage IIA Breast Cancer AJCC v8; Prognostic Stage IIB Breast Cancer AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8
NCT00543127

Terminated

Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

Conditions: Breast Cancer
NCT01183390

Completed

Anastrozole 1 mg Tablets Under Fed Conditions

Conditions: Healthy
NCT00256217

Active, not recruiting

Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women

Conditions: DCIS
NCT00244959

Completed

Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer

Conditions: Breast Cancer
NCT02942355

Recruiting

Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer

Conditions: Female Breast Carcinoma
NCT01545336

Completed

Anastrozole in Patients With Pulmonary Arterial Hypertension

Conditions: Pulmonary Arterial Hypertension
NCT04113863

Recruiting

ATRA Trial - ACTIVITY OF ATRA IN COMBINATION WITH ANASTROZOLE IN PRE-OPERATIVE PHASE OF OPERABLE HR-POSITIVE/HER2-NEGATIVE EARLY BREAST CANCER eBC ATRA TRIAL

Conditions: Breast Neoplasm Female
NCT01016665

Completed

Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy

Conditions: Breast Cancer
NCT01182181

Completed

Anastrozole 1 mg Tablets Under Fasting Conditions

Conditions: Healthy
NCT00481845

Terminated

Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer

Conditions: Breast Cancer
NCT00077025

Completed

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

Conditions: Breast Cancer
NCT00301457

Active, not recruiting

Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer

Conditions: Breast Cancer